Information on the Target
Perkant Tech, an innovative company based in Indore, India, has developed a cutting-edge AI-Enabled Med-tech Multi-disease Prognostic Health Platform. Founded in 2020 during the COVID-19 pandemic by two final-year engineering students, Lokant Jain and Saniya Jeswani, the company aims to transform healthcare delivery. Their platform provides a suite of AI-enhanced health solutions that equip individuals and healthcare professionals with predictive insights for disease prevention and ongoing health monitoring.
Perkant Tech’s flagship product, Abhay Parimiti, utilizes patented technology to deliver rapid health assessments, generating vital health insights in under a minute. The company holds both a granted Indian patent and a pending U.S. patent for its unique apparatus that evaluates psychological and physiological distress indicators. This sustainable and adaptable platform is dedicated to promoting equitable healthcare, assisting in bridging critical gaps in accessibility.
Industry Overview in India
The Indian healthcare industry is rapidly evolving, with a significant focus on integrating advanced technologies such as artificial intelligence to enhance patient outcomes. Driven by rising health concerns and a growing demand for quality healthcare services, the industry is expected to experience robust growth in the coming years. The government of India is actively supporting digital health initiatives, aligning with the National Digital Health Mission (NDHM) to improve healthcare delivery and accessibility.
Furthermore, the increasing prevalence of chronic diseases and the strain placed on healthcare infrastructure due to the pandemic have led to an emphasis on preventive care and remote health monitoring solutions. Startups like Perkant Tech are stepping up to meet these demands, utilizing innovative technologies to provide scalable and affordable healthcare solutions.
Investments in digital health startups are on the rise, as investors recognize the potential impact of these technologies on health outcomes. This wave of funding is crucial for startups aiming to develop and implement health tech solutions in both urban and rural settings across India.
The overall shift towards a more tech-driven healthcare landscape presents significant opportunities for companies focused on AI and data analytics to capture market share, as the industry identifies the need for efficient, accessible, and personalized health services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The recent seed funding round in which Perkant Tech raised INR 6.6 Crore is strategically aimed at enhancing its AI-driven prognostic technology, accelerating research and development, and facilitating market expansion. With backing from YourNest Venture Capital and various government initiatives, Perkant Tech is positioned to refine its offerings and prepare for a larger commercial launch following successful pilot programs.
This investment signifies confidence in not only the technology itself but also the company's vision of making healthcare more accessible for all individuals, especially in underserved regions. The infusion of funds will enable Perkant Tech to advance its technology upgrades and software development, ensuring that their solutions can scale efficiently and cater to a wider audience.
Information About the Investor
YourNest Venture Capital is a prominent venture capital firm known for investing in innovative startups that leverage technology to solve pressing challenges across various industries. Their investment strategy emphasizes the importance of groundbreaking solutions in sectors like healthcare, with a particular focus on scalability and affordability.
Dr. Vivek Mansingh, General Partner at YourNest, expressed the firm's enthusiasm for supporting Perkant Tech’s mission to revolutionize healthcare accessibility. According to him, the unique features of Perkant Tech’s device address significant healthcare needs, positioning the company for substantial growth and impact within the sector.
View of Dealert
In expert opinions, the investment in Perkant Tech is viewed as a promising opportunity within the burgeoning Indian healthcare landscape. The firm’s commitment to using AI-driven technology to enhance health outcomes aligns with current trends in digital health, reflecting a move toward more proactive healthcare solutions.
Given the increasing demand for accessible and preventive healthcare, the company’s focus on non-invasive health monitoring positions it as a potential leader in the field. The integration of cutting-edge technology with an empathetic approach toward patient care ensures that Perkant Tech addresses key challenges within the healthcare system effectively.
The backing from credible investors like YourNest and government initiatives provides a robust framework for growth. This not only supports the startup during its crucial development phase but also enhances its reputation in the competitive health-tech industry.
Overall, if Perkant Tech successfully delivers on its promises and follows through on its strategies, this investment could yield significant returns while simultaneously making meaningful contributions to healthcare accessibility in India.
Similar Deals
LUMO Labs, Ship2B Ventures, Athos Capital, Namarel Ventures → Sycai Medical
2025
LUMO Labs, Heran Partners, imec.istart future fund → Nuclivision
2025
YourNest Venture Capital
invested in
Perkant Tech
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $1M